Basic Information

Symbol
circGCN1L1
RNA Class
circRNA
Alias
GCN1 Activator Of EIF2AK4 KIAA0219 GCN1L1 GCN1L GCN1 (General Control Of Amino-Acid Synthesis 1, Yeast)-Like 1 General Control Of Amino-Acid Synthesis 1-Like Protein 1 GCN1, EIF2 Alpha Kinase Activator Homolog GCN1 EIF-2-Alpha Kinase Activator Homolog Stalled Ribosome Sensor GCN1 Translational Activator GCN1 GCN1-Like Protein 1 HsGCN1 Peroxisome Proliferator Activated Receptor Interacting Complex Protein GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 (Yeast) GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 EIF-2-Alpha Kinase Activator GCN1 PRIC295
Location (GRCh37)
12:120567080-120632513 UCSC Genome Browser
Location (GRCh38)
Host gene
GCN1L1
Host category
mRNA
Forensic tag(s)
Other applications
External database

Transcripts

ID Type Location (GRCh37) Location (GRCh38) Length GC content
hsa_GCN1L1_0018000 Exon-Exon chr12:120607973-120608125 chr12:120170169-120170321 153 nt 0.5686
hsa_GCN1L1_0018100 Exon-Exon chr12:120607973-120614020 chr12:120170169-120176217 681 nt 0.5448
hsa_GCN1L1_0018200 Exon-Exon chr12:120607973-120616562 chr12:120170169-120178759 994 nt 0.5352
hsa_GCN1L1_0018500 Exon-Exon chr12:120611457-120611973 chr12:120173653-120174169 273 nt 0.5311
hsa_GCN1L1_0018600 Exon-Exon chr12:120611457-120614020 chr12:120173653-120176217 528 nt 0.5379
hsa_GCN1L1_0018700 Exon-Exon chr12:120611457-120615358 chr12:120173653-120177555 637 nt 0.5259
hsa_GCN1L1_0018800 Exon-Exon chr12:120611457-120628203 chr12:120173653-120190400 1348 nt 0.5356
hsa_GCN1L1_0019200 Exon-Exon chr12:120611875-120615358 chr12:120174071-120177555 463 nt 0.5313
hsa_GCN1L1_0019400 Exon-Exon chr12:120612965-120614020 chr12:120175162-120176217 255 nt 0.5451
hsa_GCN1L1_0019500 Exon-Exon chr12:120612965-120615555 chr12:120175162-120177752 433 nt 0.5150
Showing 131 to 140 of 152 entries
Forensic Context

A review consolidating existing research indicates that in various mammalian species, the circGCN1L1 serves as an example where its expression was experimentally abolished using CRISPR/Cas9 genome-editing without affecting the expression of its corresponding linear mRNA [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].